Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > AVANIR PHARMACEUTICALS (AVNR)

Wish I'd bought more on the dip. Go AVNR!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
BHNM Member Profile
 
Followed By 0
Posts 149
Boards Moderated 0
Alias Born 04/29/10
160x600 placeholder
Avanir Pharmaceuticals Announces Publication of Pivotal Phase III Results from AVP-825 Acute Migraine Study in the Journal "H... "PR Newswire (US)" - 10/30/2014 4:01:00 PM
Avanir Pharmaceuticals Announces Presentation of AVP-923 Phase II Results in Agitation in Patients with Alzheimer's Disease a... "PR Newswire (US)" - 10/13/2014 4:26:00 PM
Avanir Pharmaceuticals to Host Investor Briefing on October 15, 2014 "PR Newswire (US)" - 10/8/2014 4:15:00 PM
Avanir Pharmaceuticals Announces Data Presentations at the American Neurological Association's (ANA) 2014 Annual Meeting Incl... "PR Newswire (US)" - 10/8/2014 8:30:00 AM
Avanir Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purc... "PR Newswire (US)" - 9/29/2014 9:15:00 AM
Avanir Pharmaceuticals Announces Pricing of Public Offering of Common Stock "PR Newswire (US)" - 9/23/2014 10:00:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 9/22/2014 5:31:17 PM
Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock "PR Newswire (US)" - 9/22/2014 4:45:00 PM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) "Edgar (US Regulatory)" - 9/22/2014 4:41:02 PM
U.S. Hot Stocks: Hot Stocks to Watch "Dow Jones News" - 9/16/2014 12:13:33 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/15/2014 12:43:21 PM
Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzhe... "PR Newswire (US)" - 9/15/2014 8:30:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 9/12/2014 10:29:24 AM
Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference "PR Newswire (US)" - 9/2/2014 9:00:00 AM
Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Dis... "PR Newswire (US)" - 8/26/2014 9:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/7/2014 6:03:15 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/5/2014 4:21:49 PM
Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update "PR Newswire (US)" - 8/5/2014 4:01:00 PM
Avanir Pharmaceuticals to Participate in Two Conferences in August "PR Newswire (US)" - 8/5/2014 8:30:00 AM
Avanir Pharmaceuticals Announces Date of Fiscal 2014 Third Quarter Financial Results and Conference Call "GlobeNewswire Inc." - 7/28/2014 8:30:00 AM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 7/22/2014 4:33:32 PM
Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder "PR Newswire (US)" - 7/21/2014 9:15:00 AM
Avanir Pharmaceuticals Announces Presentation of Positive Early Results from PRISM II Study "PR Newswire (US)" - 7/16/2014 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/10/2014 7:42:09 PM
Avanir Pharmaceuticals Announces Two Data Presentations Related to Pseudobulbar Affect (PBA) at the Alzheimer's Association I... "PR Newswire (US)" - 6/30/2014 7:22:00 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist